Greenlight Score
Six-dimension verdict tier-classified into Canonical / Distinguished / Certified / Verified / Develop / Reject. Anchored to canonical excellence, audit-grade confidence, defensible in committee review.
ReelPen turns scripts and manuscripts into auditable, page-cited reports. Powered by a wholly proprietary algorithmic system — no open-source models, no third-party LLM wrappers, no off-the-shelf components. Used by acquisition teams, lit agents, and development executives to triage submissions with the rigor of a quant desk.
Currently in private beta with a small group of partner studios and agencies. Public launch later this year.
Six-dimension verdict tier-classified into Canonical / Distinguished / Certified / Verified / Develop / Reject. Anchored to canonical excellence, audit-grade confidence, defensible in committee review.
Reader-grade coverage augmented with structural diagnostics. Replaces or stress-tests your in-house first-pass workflow.
Structural triage with prioritized rewrite recommendations, each citing the page and beat that triggered the flag.
Dialogue distinctiveness, naturalism, subtext density, and genre-fit metrics — measured against comparable canon.
Forecast a script's market trajectory before greenlight. Cast power · director track record · release window · genre saturation · adaptation status — all factored. Returns expected reception band within ±5pt of actual outcome.
All fifteen modules consolidated — Module #14 Structure Detector + Module #15 Extrinsic Risk Forecasting included. Built for acquisition committees and slate reviews.
Upload PDF, FDX, or pasted text. The engine normalizes scenes, beats, and dialogue into a structured representation.
Six dimensions scored against the benchmark set. Confidence intervals attached. Outliers flagged for human review.
Each finding is linked to the specific page, beat, or scene that triggered it. Every claim is auditable.
Signed PDF report, structured JSON, or direct hand-off into your acquisition pipeline via API.
We cut external coverage spend by 47% in the first quarter. The verdicts are sharper than half our freelance pool, and the citations make it actionable in a slate meeting.
The Market Validator brief is what we walk into every greenlight conversation with now. The comparable-vector approach catches positioning we would have missed in committee.
Our agents triage 40+ submissions a week. ReelPen's coverage tier replaced our outsourced first-pass entirely — the SLA alone justified the switch.
For a publisher pivoting into IP licensing, the adaptation-readiness signals are the most valuable single tool we've adopted in five years.